Detalhe da pesquisa
1.
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
Cephalalgia
; 44(2): 3331024241235156, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410850
2.
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
J Headache Pain
; 24(1): 115, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612633
3.
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.
Cephalalgia
; 42(14): 1543-1564, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36081276
4.
Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3.
Ophthalmol Ther
; 12(3): 1671-1692, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967448
5.
Costs comparison of treating diabetic macular edema with aflibercept, ranibizumab or dexamethasone at 1 year in France (INVICOST study).
Eur J Ophthalmol
; 32(3): 1702-1709, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284605
6.
Real-Life Efficacy, Safety, and Use of Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-infectious Uveitis (LOUVRE 2 Study).
Ophthalmol Ther
; 11(5): 1775-1792, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802252
7.
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data.
J Med Econ
; 24(1): 1087-1097, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420480